Therapeutic application of PPE2 protein of Mycobacterium tuberculosis in inhibiting tissue inflammation
Abstract: There is an increasing need to develop biological anti‐inflammatory agents that are more targeted, effective, and with lesser side effects as compared to conventional chemical drugs. In the present study, we found that Mycobacterium tuberculosis protein PPE2 and a synthetic derivative peptide can suppress the mast cell population and inhibit several vasoactive and fibrogenic mediators and pro‐inflammatory cytokines induced by mast cells in formalin‐induced tissue injury. PPE2 was found to inhibit transcription from the promoter of stem cell factor, important for mast cell maintenance and migration. Thus, PPE2/peptide can be used as a potent nonsteroidal therapeutic agent for the treatment of inflammation and tissue injury.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Therapeutic application of PPE2 protein of Mycobacterium tuberculosis in inhibiting tissue inflammation ; day:11 ; month:07 ; year:2022 ; extent:28
EMBO molecular medicine / European Molecular Biology Organization ; (11.07.2022) (gesamt 28)
- Creator
-
Pal, Ravi
Battu, Madhu Babu
Mukhopadhyay, Sangita
- DOI
-
10.15252/emmm.202114891
- URN
-
urn:nbn:de:101:1-2022071115113675926938
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
12.03.2026, 12:11 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pal, Ravi
- Battu, Madhu Babu
- Mukhopadhyay, Sangita
Other Objects (12)
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening
Mycobacterium tuberculosis Rv2626c‐derived peptide as a therapeutic agent for sepsis
Tab. 48 Mycobacterium tuberculosis
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
Arginine assimilation in mycobacterium tuberculosis and mycobacterium smegmatis
Autoimmune keratitis in mycobacterium tuberculosis
Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Adenylatcyclasen Rv2435c und Rv2212c aus Mycobacterium tuberculosis : = Mycobacterium tuberculosis adenylyl cyclases Rv2435c and Rv2212c
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening
Mycobacterium tuberculosis Rv2626c‐derived peptide as a therapeutic agent for sepsis
Tab. 48 Mycobacterium tuberculosis
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
Arginine assimilation in mycobacterium tuberculosis and mycobacterium smegmatis
Autoimmune keratitis in mycobacterium tuberculosis
Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Adenylatcyclasen Rv2435c und Rv2212c aus Mycobacterium tuberculosis : = Mycobacterium tuberculosis adenylyl cyclases Rv2435c and Rv2212c
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening
Mycobacterium tuberculosis Rv2626c‐derived peptide as a therapeutic agent for sepsis
Tab. 48 Mycobacterium tuberculosis
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
Arginine assimilation in mycobacterium tuberculosis and mycobacterium smegmatis
Autoimmune keratitis in mycobacterium tuberculosis
Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Adenylatcyclasen Rv2435c und Rv2212c aus Mycobacterium tuberculosis : = Mycobacterium tuberculosis adenylyl cyclases Rv2435c and Rv2212c